Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation34

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation18

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20255
March 202513
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States2
 

Top cities views

Views
Buffalo1